FDA (Tag Archives)

Subscribe to PricePlow's Newsletter and FDA Alerts

TopicBlog PostsYouTube Videos
FDA

Hi-Tech Appeals to Get its Wrongfully-Confiscated DMAA Back

Hi-Tech Fights Back for DMAA Update December 28, 2017: Hi-Tech Pharmaceuticals has appealed the Magistrate Judge’s decision denying their request to release the recently-confiscated DMAA. This is the last “short-term” stand to get DMAA back, outside of the greater DMAA lawsuit appeal, which is the […]

Continue Reading →

Posted on by in , | 131 Comments

Lyman Good’s Failed Drug Test Raises Questions about USADA and Gaspari Anavite

Gaspari Anavite Lab Test

On October 24, 2016, the US Anti-Doping Agency (USADA) notified Lyman Good of a potential drug test violation taken on October 14, 2016.[1] It was later disclosed that the then 31 year old tested for the illegal prohormone 1-androstenedione (sometimes […]

Continue Reading →

Posted on by in , | 34 Comments

SARMs on the Ropes: FDA Finally Issues Warning Letters

FDA SARMs

Don’t look now meatheads, but SARMs are officially under fire from the FDA – only two years after we predicted it’d happen!

It’s been a particularly tumultuous few weeks for the supplement industry. Recently we’ve seen Hi-Tech Pharmaceuticals raided, […]

Continue Reading →

Posted on by in , | 1 Comment

Keto Connect Podcast with Mike from PricePlow: Supplements for Keto | #4

KetoConnect Podcast

In the fall of 2017, I had the honor of being one of KetoConnect’s first podcast interviewees!

Matt and Megha, the champions of all things keto food and keto recipes, asked me to come on and discuss supplements on the […]

Continue Reading →

Posted on by in , | Comments

Olympus Labs Re1gn RECALL Announcement (Update: All Customers Contacted!)

Olympus Labs Re1gn Recall

UPDATE: We’ve spoken to the representative mentioned below at Olympus Labs who assured us that they are doing everything possible to contact all customers who received the Dragon’s Mist flavor of Re1gn, or have the retail store contact them.

Our […]

Continue Reading →

Posted on by in , | 3 Comments

The Daniel Armstrong / Ying Zhang DMAA Study Scandal: “1,3-Dimethylamylamine (DMAA) in supplements and geranium products: natural or synthetic?”

DMAA Found in Geranium and Covered Up

This is part three of a six page series researching whether DMAA (1,3 dimethylamylamine) is a natural constituent of geranium flowers. All six parts are linked from our main DMAA in Nature / Geranium page.

In our previous article, […]

Continue Reading →

Posted on by in , | No Comments

Ping, Li, and Fleming: The Three Disputed Studies Where DMAA Was Found in Geranium

DMAA in Geranium - The Disputed Studies

This is part one of a six page series researching whether DMAA (1,3 dimethylamylamine) is a natural constituent of geranium flowers. All six parts are linked from our main DMAA in Nature / Geranium page.

Note from Mike, Founder of […]

Continue Reading →

Posted on by in , | No Comments

The Ten (Actually 11!) Times DMAA was Found in Nature (in Geraniums)

DMAA Geranium

One of the most pivotal parts of the DMAA Lawsuit between Hi-Tech Pharmaceuticals and the FDA is whether or not DMAA is found in nature. Specifically, is the stimulant (also known as 1,3 dimethylamylamine) a natural constituent of certain […]

Continue Reading →

Posted on by in | No Comments

Eria Jarensis Extract / N-phenethyl dimethylamine: The Next Big Thing?

N-Phenethyldimethylamine 2D Receptor with Protection Highlighted

Here in the sports nutrition industry, we’re always looking for the “Next Big Stimulant”. Something to take you to the next level.

Here in the summer of 2015, that next compound may have arrived, by way of N-Phenyldimethylamine or […]

Continue Reading →

Posted on by in , , | 2 Comments

Hi-Tech Pharma Files Motion to Vacate DMAA Judgment

DMAA Lawsuit Motion to Vacate

Earlier today (April 17, 2017), Hi-Tech Pharmaceuticals filed two motions in their lawsuit against the FDA, in an effort to keep their DMAA Supplements legal and on the market.

The motions can be downloaded below, followed by some commentary […]

Continue Reading →

Posted on by in , | No Comments